A phase I pharmacokinetic and safety study of WP-1303 in healthy volunteers

Trial Profile

A phase I pharmacokinetic and safety study of WP-1303 in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Mar 2017

At a glance

  • Drugs WP 1303 (Primary)
  • Indications Glaucoma; Ocular hypertension
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 15 Mar 2017 Status changed from recruiting to completed, according to a D. Western Therapeutics Institute media release.
    • 04 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top